Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksSabre Insur Regulatory News (SBRE)

Share Price Information for Sabre Insur (SBRE)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 164.80
Bid: 163.20
Ask: 164.80
Change: 2.40 (1.48%)
Spread: 1.60 (0.98%)
Open: 162.00
High: 164.80
Low: 162.00
Prev. Close: 162.40
SBRE Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Trading Update

13 Oct 2022 07:00

RNS Number : 7077C
Sabre Insurance Group PLC
13 October 2022
 

13 October 2022

 

Sabre Insurance Group plc

 

Trading Update

Guidance for the Full Year reiterated

 

Sabre Insurance Group plc (the "Group" or "Sabre"), one of the UK's leading motor insurance underwriters, today provides an update on trading for the period from 1 July 2022 to 30 September 2022.

Geoff Carter, Chief Executive Officer of Sabre, commented:

"I am pleased with the resilience of our performance through to the end of the third quarter. We have continued to focus on both margin over volume and fully covering the ongoing high levels of claims inflation through price increases that are significantly higher than the market. This consistent strategy ensures that Sabre remains on a sound financial and operational footing for the times ahead. 

It is encouraging that despite our above-market price increases we are still delivering volumes in line with our expectations. It is pleasing that we are seeing the planned improvement in our Motor loss ratio.

We have benefitted from writing more Motorcycle business than planned which will generate some natural first year growth strain. As this growth strain subsides the volumes written in our Motorcycle and Taxi businesses will make attractive ongoing profit contributions as our pricing discipline and underwriting initiatives flow through.

The resilience of our Motor performance, and future profit streams from Motorcycle and Taxi, mean that despite the ongoing macro and geo-political uncertainties, we are looking forward with confidence as our specialist offering and discipline over the recent challenging periods pays dividends."

Financial highlights

Unaudited

Unaudited

Audited

9 months ended

9 months ended

12 months ended

 30 Sept 2022

30 Sept 2021

31 December 2021

Gross written premium

£135.7m

£126.7m

£169.3m

Gross written premium - Motor

£105.2m

£125.5m

£164.6m*

Gross written premium - Motorcycle

£20.9m

£Nil

£3.2m

Gross written premium - Taxi

£9.6m

£1.2m

£1.5m*

Post-dividend solvency capital ratio

163%

175%

164%

 *Motor and Taxi split not previously disclosed and split not audited

Navigating the inflationary environment

Our analysis suggests that the broader market rate increases reported for the year to date are between 10% and 11%, with approximately half of this market rate rise in response to the new FCA pricing rules and half of the market rate rise a direct response to claims inflation. 

However, we believe that claims inflation itself is currently running at approximately 12%, meaning that we continue to anticipate a market-wide correction through the final quarter of the year and the first quarter of next year. There are some early signs of an acceleration of price increase by many competitors in recent weeks.

In response to this inflationary environment - and in contrast to the broader market - Sabre has continued to increase prices to reflect claims inflation fully, increasing Motor policy prices by 24% to the end of September 2022, and by 31% over the past twelve months. Our volumes continue to be in line with expectation.

Consequently, we reiterate our guidance for the Full Year and anticipate a combined operating ratio in the mid-90%'s that we expect will improve significantly in 2023. 

Long term confidence

Sabre has a strong market position within its Motor business and has proven through this cycle its ability to mitigate inflation with price increases. Sabre's diversification into the complementary Motorcycle and Taxi businesses has created new areas of specialist growth and will make profitable contributions going forward. 

This strategy is underpinned by a well-funded balance sheet, with no debt, and with a strong ongoing solvency capital position, above our target range of 140% to 160%. Additionally, Sabre's investment portfolio is low risk and operates a matching policy to ensure that movements in interest/risk-free rates have a minimal impact on its solvency position. 

The Board remains very confident in the long-term prospects of the business.

 

Investor enquiries

01306 747 272

Sabre Insurance Group plc

investor.relations@sabre.co.uk

Geoff Carter / Adam Westwood

Media enquiries

020 7353 4200

Tulchan Communications

sabre@tulchangroup.com

James Macey White / Guy Bates

 

LEI Code: 2138006RXRQ8P8VKGV98

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTFFLFMEEESEDS
Date   Source Headline
23rd Apr 20244:00 pmRNSHolding(s) in Company
22nd Apr 20243:22 pmRNSHolding(s) in Company
19th Apr 20248:51 amRNSChair Appointment
18th Apr 202411:22 amRNSDirector Declaration
11th Apr 202412:41 pmRNSDirector/PDMR Shareholding
11th Apr 202412:07 pmRNSDirector/PDMR Shareholding
9th Apr 20242:44 pmRNSDirector/PDMR Shareholding
5th Apr 20243:48 pmRNSNotice of AGM
21st Mar 202412:30 pmRNSDirector/PDMR Shareholding
19th Mar 20247:00 amRNSFull-year results 2023
13th Mar 20249:33 amRNSNotice of Results
12th Mar 20242:16 pmRNSDirector/PDMR Shareholding
12th Mar 202412:14 pmRNSDirector Declaration
16th Feb 20241:52 pmRNSHolding(s) in Company
15th Feb 20247:00 amRNSTrading Statement
13th Feb 20242:18 pmRNSDirector/PDMR Shareholding
11th Jan 202411:11 amRNSDirector/PDMR Shareholding
20th Dec 20232:24 pmRNSHolding(s) in Company
12th Dec 202312:03 pmRNSDirector/PDMR Shareholding
28th Nov 20234:27 pmRNSDirectorate Change
27th Nov 20234:42 pmRNSRemuneration Committee Chair Appointment
22nd Nov 20238:51 amRNSNotification of cyber incident
20th Nov 20237:00 amRNSDeath of Chair
13th Nov 202311:44 amRNSDirector/PDMR Shareholding
19th Oct 20237:00 amRNSTrading Update
11th Oct 202312:52 pmRNSDirector/PDMR Shareholding
25th Sep 20233:39 pmRNSDirector/PDMR Shareholding
21st Sep 202311:48 amRNSDirector/PDMR Shareholding
14th Sep 20232:25 pmRNSHolding(s) in Company
13th Sep 202310:00 amRNSDirector/PDMR Shareholding
13th Sep 20239:33 amRNSDirectorate Change
11th Aug 202310:07 amRNSDirector/PDMR Shareholding
3rd Aug 20237:00 amRNSHalf-year Report 2023
25th Jul 20238:53 amRNSDirector Declaration
11th Jul 20232:57 pmRNSDirector/PDMR Shareholding
13th Jun 202310:09 amRNSDirector/PDMR Shareholding
2nd Jun 20233:02 pmRNSDirector/PDMR Shareholding
25th May 202311:22 amRNSResult of AGM
25th May 20239:27 amRNSDirector/PDMR Shareholding
25th May 20237:01 amRNSBoard Appointment
25th May 20237:00 amRNSTrading Update
11th May 202311:42 amRNSDirector/PDMR Shareholding
18th Apr 20233:19 pmRNSDirector/PDMR Shareholding
12th Apr 202311:53 amRNSDirector/PDMR Shareholding
6th Apr 202312:28 pmRNSDirector/PDMR Shareholding
31st Mar 20233:43 pmRNSNotice of AGM
31st Mar 20233:37 pmRNSDirector/PDMR Shareholding
14th Mar 20237:00 amRNSFinal Results
13th Mar 202312:13 pmRNSDirector/PDMR Shareholding
13th Feb 20231:51 pmRNSDirector/PDMR Shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.